Anisodamine

Overview

Anisodamine has been investigated for the treatment of Intestinal Diseases.

Indication

1.感染中毒性休克：如爆发性流行性脑脊髓膜炎、中毒性痢疾等（需要与抗生素合用）； 2.血管痉挛和栓塞引起的循环障碍：脑血栓形成、脑栓塞、瘫痪、脑血管痉挛、血管神经性头痛、血栓闭塞性脉管炎等； 3.平滑肌痉挛：胃溃疡、十二指肠溃疡、胆管、胰管、输尿管急性痉挛引起的绞痛或疼痛； 4.各种神经痛：如三叉神经痛、坐骨神经痛等； 5.眩晕病； 6.眼底疾病：中心性视网膜炎、视网膜色素变性、视网膜动脉血栓等； 7.突发性耳聋； 8.也用于有机磷中毒，但效果不如阿托品好； 9.其滴眼液可用于因睫状肌痉挛所造成的假性近视。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation	2023/09/21	NCT06045364	Phase 1	Active, not recruiting	Jie Chen
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients	2023/02/14	NCT05727163	Phase 2	Recruiting	Sun Yat-sen University
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis	2022/12/01	NCT05634057	Not Applicable	Recruiting	Chen Ying
A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis	2021/02/21	NCT04761627	Phase 3	Completed	Amgen
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis	2020/10/29	NCT04607980	Phase 3	Completed	Amgen
Anisodamine Critically Ill SeptIc Shock	2015/05/13	NCT02442440	Phase 1	Completed	Jinhua Central Hospital

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access